vs

Side-by-side financial comparison of Adaptive Biotechnologies Corp (ADPT) and A10 Networks, Inc. (ATEN). Click either name above to swap in a different company.

A10 Networks, Inc. is the larger business by last-quarter revenue ($75.0M vs $70.9M, roughly 1.1× Adaptive Biotechnologies Corp). A10 Networks, Inc. runs the higher net margin — 16.0% vs 4.7%, a 11.3% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 13.4%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs 11.7%).

ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.

A10 Networks, Inc. is an American public company specializing in the manufacturing of application delivery controllers. Founded in 2004 by Lee Chen, co-founder of Foundry Networks, A10 originally serviced just the identity management market with its line of ID Series products. In early 2007, they added bandwidth management appliances. The company had its initial public offering on March 21, 2014, raising $187.5 million.

ADPT vs ATEN — Head-to-Head

Bigger by revenue
ATEN
ATEN
1.1× larger
ATEN
$75.0M
$70.9M
ADPT
Growing faster (revenue YoY)
ADPT
ADPT
+21.7% gap
ADPT
35.1%
13.4%
ATEN
Higher net margin
ATEN
ATEN
11.3% more per $
ATEN
16.0%
4.7%
ADPT
Faster 2-yr revenue CAGR
ADPT
ADPT
Annualised
ADPT
28.1%
11.7%
ATEN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ADPT
ADPT
ATEN
ATEN
Revenue
$70.9M
$75.0M
Net Profit
$3.4M
$12.0M
Gross Margin
73.6%
79.6%
Operating Margin
-27.1%
17.3%
Net Margin
4.7%
16.0%
Revenue YoY
35.1%
13.4%
Net Profit YoY
EPS (diluted)
$0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ADPT
ADPT
ATEN
ATEN
Q1 26
$70.9M
$75.0M
Q4 25
$71.7M
$80.4M
Q3 25
$94.0M
$74.7M
Q2 25
$58.9M
$69.4M
Q1 25
$52.4M
$66.1M
Q4 24
$47.5M
$74.2M
Q3 24
$46.4M
$66.7M
Q2 24
$43.2M
$60.1M
Net Profit
ADPT
ADPT
ATEN
ATEN
Q1 26
$3.4M
$12.0M
Q4 25
$-13.6M
$9.9M
Q3 25
$9.5M
$12.2M
Q2 25
$-25.6M
$10.5M
Q1 25
$-29.9M
$9.5M
Q4 24
$-33.7M
$18.3M
Q3 24
$-32.1M
$12.6M
Q2 24
$-46.2M
$9.5M
Gross Margin
ADPT
ADPT
ATEN
ATEN
Q1 26
73.6%
79.6%
Q4 25
74.6%
78.7%
Q3 25
80.7%
80.1%
Q2 25
69.4%
78.9%
Q1 25
67.6%
79.7%
Q4 24
62.0%
79.9%
Q3 24
64.1%
80.5%
Q2 24
55.3%
80.0%
Operating Margin
ADPT
ADPT
ATEN
ATEN
Q1 26
-27.1%
17.3%
Q4 25
-17.8%
18.7%
Q3 25
10.9%
17.4%
Q2 25
-42.5%
14.9%
Q1 25
-56.4%
13.3%
Q4 24
-71.3%
24.8%
Q3 24
-70.3%
15.7%
Q2 24
-109.6%
13.2%
Net Margin
ADPT
ADPT
ATEN
ATEN
Q1 26
4.7%
16.0%
Q4 25
-18.9%
12.3%
Q3 25
10.2%
16.3%
Q2 25
-43.5%
15.2%
Q1 25
-56.9%
14.4%
Q4 24
-71.0%
24.7%
Q3 24
-69.1%
18.9%
Q2 24
-107.0%
15.8%
EPS (diluted)
ADPT
ADPT
ATEN
ATEN
Q1 26
$0.17
Q4 25
$-0.08
$0.13
Q3 25
$0.06
$0.17
Q2 25
$-0.17
$0.14
Q1 25
$-0.20
$0.13
Q4 24
$-0.22
$0.24
Q3 24
$-0.22
$0.17
Q2 24
$-0.31
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ADPT
ADPT
ATEN
ATEN
Cash + ST InvestmentsLiquidity on hand
$77.6M
$57.9M
Total DebtLower is stronger
$219.2M
Stockholders' EquityBook value
$220.8M
Total Assets
$505.9M
$634.4M
Debt / EquityLower = less leverage
0.99×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ADPT
ADPT
ATEN
ATEN
Q1 26
$77.6M
$57.9M
Q4 25
$70.5M
$684.6M
Q3 25
$55.0M
$370.9M
Q2 25
$43.2M
$367.4M
Q1 25
$50.6M
$355.8M
Q4 24
$47.9M
$195.6M
Q3 24
$38.1M
$182.1M
Q2 24
$59.8M
$177.1M
Total Debt
ADPT
ADPT
ATEN
ATEN
Q1 26
$219.2M
Q4 25
$218.8M
Q3 25
$218.4M
Q2 25
$218.1M
Q1 25
$217.7M
Q4 24
$0
Q3 24
Q2 24
Stockholders' Equity
ADPT
ADPT
ATEN
ATEN
Q1 26
$220.8M
Q4 25
$218.8M
$211.5M
Q3 25
$204.4M
$206.2M
Q2 25
$179.7M
$204.0M
Q1 25
$190.4M
$195.9M
Q4 24
$202.7M
$231.8M
Q3 24
$223.8M
$217.3M
Q2 24
$241.6M
$214.4M
Total Assets
ADPT
ADPT
ATEN
ATEN
Q1 26
$505.9M
$634.4M
Q4 25
$512.7M
$629.8M
Q3 25
$490.6M
$620.1M
Q2 25
$496.6M
$607.9M
Q1 25
$510.9M
$606.2M
Q4 24
$539.4M
$432.8M
Q3 24
$558.5M
$407.7M
Q2 24
$584.9M
$397.2M
Debt / Equity
ADPT
ADPT
ATEN
ATEN
Q1 26
0.99×
Q4 25
1.03×
Q3 25
1.06×
Q2 25
1.07×
Q1 25
1.11×
Q4 24
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ADPT
ADPT
ATEN
ATEN
Operating Cash FlowLast quarter
$2.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.19×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ADPT
ADPT
ATEN
ATEN
Q1 26
$2.2M
Q4 25
$2.1M
$22.7M
Q3 25
$-7.1M
$22.8M
Q2 25
$-12.4M
$22.2M
Q1 25
$-28.5M
$17.2M
Q4 24
$-12.5M
$25.7M
Q3 24
$-27.1M
$20.1M
Q2 24
$-17.3M
$12.2M
Free Cash Flow
ADPT
ADPT
ATEN
ATEN
Q1 26
Q4 25
$1.4M
$16.0M
Q3 25
$-7.5M
$18.1M
Q2 25
$-13.1M
$17.9M
Q1 25
$-29.7M
$12.7M
Q4 24
$-12.6M
$23.3M
Q3 24
$-27.4M
$16.7M
Q2 24
$-19.0M
$8.7M
FCF Margin
ADPT
ADPT
ATEN
ATEN
Q1 26
Q4 25
2.0%
20.0%
Q3 25
-8.0%
24.2%
Q2 25
-22.2%
25.9%
Q1 25
-56.7%
19.2%
Q4 24
-26.5%
31.4%
Q3 24
-59.0%
25.0%
Q2 24
-44.1%
14.5%
Capex Intensity
ADPT
ADPT
ATEN
ATEN
Q1 26
3.9%
Q4 25
0.9%
8.3%
Q3 25
0.4%
6.3%
Q2 25
1.1%
6.1%
Q1 25
2.4%
6.8%
Q4 24
0.2%
3.2%
Q3 24
0.7%
5.2%
Q2 24
4.0%
5.8%
Cash Conversion
ADPT
ADPT
ATEN
ATEN
Q1 26
0.19×
Q4 25
2.30×
Q3 25
-0.75×
1.87×
Q2 25
2.10×
Q1 25
1.80×
Q4 24
1.40×
Q3 24
1.59×
Q2 24
1.29×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ADPT
ADPT

Segment breakdown not available.

ATEN
ATEN

Products$44.0M59%
Services$31.0M41%

Related Comparisons